Please fill out the form to subscribe now

Investors

Lateral flow testing is a high-growth industry with 1 billion tests produced in 2017.

The lateral flow test market is estimated to reach $8.24 billion by 2022.

For investment opportunities please contact our office at

Email    (902) 536-1932

Learn more about Sona’s high growth investment opportunities

VIEW INVESTOR PRESENTATION

The Sona Management Team

David Regan

David Regan

Chief Executive Officer

David joined Sona Nanotech as a consultant in the spring of 2020 to provide strategic advisory with respect to its commercialization and capital markets strategies as the company plotted a path toward developing and taking its COVID-19 test to market.

Read more
Robert Randall

Robert Randall

CFO & Corporate Secretary

Mr. Randall has served as a contract CFO for a number of TSXV-listed companies over the past five years and has extensive public company financial experience. In addition to Northwest, Rob also currently serves as the Chief Financial Officer of Metallum Resources Inc., Stockport Exploration and Canabo Medical Inc.

Read more
Darren Rowles

Darren Rowles

President and Chief Scientific Officer

16 years’ experience in nanotechnology and lateral flow diagnostics. Has introduced 15 new products to market. Mr Rowles is responsible for growing the business, expanding into new territories and ensuring Sona continues to produce innovative new products for the lateral flow diagnostics market.

Read more
Peter Romeo

Peter Romeo

Chief Revenue Officer

A commercially-minded executive, Peter has over 20 years’ experience in the Med Tech industry in senior leadership and executive Sales and Marketing roles. Peter takes a vision and makes it reality through sound strategy development.

Read more